| Literature DB >> 33061368 |
Mojgan Sheikhpour1,2, Maryam Naghinejad1,2, Alibakhsh Kasaeian3, Armaghan Lohrasbi1,2, Seyed Sadegh Shahraeini1,2, Shahab Zomorodbakhsh4.
Abstract
The importance of timely diagnosis and the complete treatment of lung cancer for many people with this deadly disease daily increases due to its high mortality. Diagnosis and treatment with helping the nanoparticles are useful, although they have reasonable harms. This article points out that the side effects of using carbon nanotube (CNT) in this disease treatment process such as inflammation, fibrosis, and carcinogenesis are very problematic. Toxicity can reduce to some extent using the techniques such as functionalizing to proper dimensions as a longer length, more width, and greater curvature. The targeted CNT sensors can be connected to various modified vapors. In this regard, with helping this method, screening makes non-invasive diagnosis possible. Researchers have also found that nanoparticles such as CNTs could be used as carriers to direct drug delivery, especially with chemotherapy drugs. Most of these carriers were multi-wall carbon nanotubes (MWCNT) used for cancerous cell targeting. The results of laboratory and animal researches in the field of diagnosis and treatment became very desirable and hopeful. The collection of researches summarized has highlighted the requirement for a detailed assessment which includes CNT dose, duration, method of induction, etc., to achieve the most controlled conditions for animal and human studies. In the discussion section, 4 contradictory issues are discussed which are invited researchers to do more research to get clearer results.Entities:
Keywords: carbon nanotubes; drug delivery; lung cancer detection; lung cancer treatment; toxicity
Mesh:
Substances:
Year: 2020 PMID: 33061368 PMCID: PMC7522408 DOI: 10.2147/IJN.S263238
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Figure 1Scheme of SWCNT originating from a graphene sheet, while MWCNT has several graphene sheets according to the size. Carbon atoms were placed next to each other in a honeycomb structure. Reprinted from International Communications in Heat and Mass Transfer, Vol 78, Yazid MNAWM, Sidik NAC, Mamat R, et al, A review of the impact of preparation on stability of carbon nanotube nanofluids, Pages No. 253–263, Copyright (2016), with permission from Elsevier.20
Figure 2Evaluation of the similarity of straight MWCNTs and asbestos, and the effect of straight, curved MWCNTs and asbestos on mesothelial cells. Indeed, curved nanotubes are less dangerous for the cell than a straight CNTs or asbestos, and could better play their carrier role.
Summary of Toxic Effects Obtained from Studies by Year Order
| Researchers | Year | Research | Toxic Effects | Citation |
|---|---|---|---|---|
| Muller et al | 2005 | MWCNTs on lungs of Sprague–Dawley rats | Inducing inflammation, pulmonary lesions, and fibrosis | |
| Srivastava et al | 2011 | MWCNTs on human’s lung cancer cell line-A549/in vitro | Making oxidative stress and apoptosis | |
| Pacurari et al | 2011 | MWCNTs on mice lungs | Inducing cancer, and changes in genes expression | |
| Wang et al | 2011 | SWCNTs on mice lungs | Inducing cancer | |
| Hong Liu | 2012 | MWCNTs on mice lungs | Producing multiple lesions | |
| Morimoto et al | 2012 | MWCNTs on mice lungs | Inducing pulmonary inflammation, and small granulomatous lesion | |
| Guo et al | 2012 | MWCNTs on mice lungs | Inducing cancer, and changes in genes expression | |
| Yu et al | 2013 | MWCNTs on male C57BL/6 mice lungs | Producing tumor | |
| Rittinghausen et al | 2014 | MWCNTs on rat lungs | Producing tumors and cancer | |
| Sargent et al | 2014 | MWCNTs on B6C3F1 mice lung | Inducing cancer | |
| Sanpui et al | 2014 | SWCNTs on small airway epithelial cells/in vitro | Increasing vulnerability to infections | |
| Luanpitpong et al | 2014 | SWCNTs on mice lungs | Inducing tumor | |
| Luanpitpong et al | 2014 | SWCNTs on human’s lung epithelial cells/in vitro | Inducing tumor | |
| Dymacek et al | 2015 | MWCNTs on mice lungs | Inducing inflammation, and fibrosis | |
| Chen et al | 2015 | SWCNTs on lungs line cells/in vitro | Inducing cancer, and changes in genes expression | |
| Virupaxi et al | 2015 | SWCNTs on rat’s lung epithelial cells/in vitro | Decreasing antioxidant levels, and inducing cell death | |
| Pongrakhananon et al | 2015 | SWCNTs on human’s lung epithelial cells/in vitro | Inducing cancer and making resistance to apoptosis | |
| Shvedova et al | 2015 | SWCNTs on human’s lung line cells/in vitro | Inducing cancer | |
| Snyder-Talkington et al | 2016 | MWCNTs on mice lungs | Inducing inflammation, and fibrosis | |
| Snyder-Talkington et al | 2016 | MWCNTs on mice lungs | Inducing inflammation, fibrosis, and lung adenocarcinoma | |
| Suzui et al | 2016 | MWCNTs on male rats lungs | Inducing malignant mesothelioma and lung tumors | |
| Kasai et al | 2016 | MWCNTs on F344 rats lungs | Inducing lung carcinomas | |
| He et al | 2016 | CNT on human’s lung line cells/in vitro | Inducing malignancies | |
| Stueckle et al | 2017 | MWCNTs on human’s lung epithelial cells/in vitro | Producing lung tumorigenesis | |
| Zhou et al | 2017 | MWCNTs on human’s lung cancer cell line/in vitro | Observing genotoxic and cytotoxicity | |
| Vlaanderen et al | 2017 | Workers in contact with MWCNTs | No functional difference in the lungs | |
| Rahman et al | 2017 | MWCNTs on mice lungs | Inducing fibrosis, cancer, chronic inflammation, changes in genes expression, and tissue irritation | |
| Voronkova et al | 2017 | SWCNTs on mice lungs | Inducing cancer, and overexpression of | |
| Wang et al | 2017 | SWCNTs on human’s lung epithelial cells/in vitro | Promoting tumor, and metastasis | |
| Dymacek et al | 2018 | MWCNTs on mice lungs | Changing in gene expression, cell proliferation, survival, oxidative phosphorylation pathway, mitochondrial dysfunction, transcription, and producing fibrosis | |
| Fukai et al | 2018 | MWCNTs on the murine lung resident cells (GDL 1) and immune cells (RAW 264.7) | Inducing mutation in GDL 1 and producing inflammatory cytokines from RAW 264.7 | |
| Nahle et al | 2019 | SWCNTs and MWCNTs on rat’s alveolar macrophage cell line | Inducing inflammation mainly by MWCNTs, while SWCNTs more relying on apoptosis and destroyed mitochondrial function | |
| Gaté et al | 2019 | MWCNTs on the lungs of Sprague–Dawley rats | Observing DNA damage | |
| Wang et al | 2020 | CNTs on the experimental animals | Inducing pleural lesions, pleural fibrosis, inflammation, lung tumors, and virulent mesothelioma | |
| Aoki et al | 2020 | MWCNT on the lungs of mice | No cancerous effect | |
| Önera et al | 2020 | MWCNT on human’s bronchial cells/in vitro | Inducing methylation changes in CpG sites, and promoters of genes |
Figure 3Summary of diagnostic cases based on the changes in polar components. Targeted CNT sensors could be connected to a variety of modified vapors. In this way, with the help of this method screening make non-invasive diagnosis possible.
Figure 4Targeted and non-targeted treatment differences. Indeed, the figure refers to the accumulation of drug to the target cell. The drug is not distributed freely in nano-drug delivery.
Review of Studies and Results of Nano-Drug Delivery by CNT in the Treatment of Lung Cancer (by Year Order)
| Researchers | Year | Type of CNTs | Functionalized with | Type of Drugs/Protein | Targeting | Results | Citations |
|---|---|---|---|---|---|---|---|
| Podesta et al | 2009 | MWCNT | Cation | siRNA | A549 | Results were desirable | |
| Datir et al | 2012 | MWCNT | Hyaluronic acid | Doxorubicin | A549 | The hopeful result was observed | |
| Arya et al | 2013 | SWCNT | Graphene oxide | paclitaxel | NCI-H460, and A549 | Treatment was effective | |
| Lodhi et al | 2013 | MWCNT | Just carboxylate | Dexamethasone | A549 | Approach was more toxic for A549 | |
| Das et al | 2013 | MWCNT | Fluorochrome | Methotrexate | A549 | The hopeful result was observed | |
| Li et al | 2014 | MWCNT | …. | Platinum | Mice lungs | Results confirmed that MWCNT are efficient nan-carrier | |
| Tan et al | 2014 | MWCNT | Just carboxylate | Betulinic acid | A549 | The drug was used in low concentrations and the results were positive | |
| Zakaria et al | 2015 | SWCNT | pyrene butyric acid N-hydroxysuccinimide ester, and Polyethylene glycol | TRAIL or Apo2L | H1703 | Treatment was effective | |
| Guo et al | 2015 | MWCNT | Cation | siRNA | Calu 6 | Anti-tumor effects were seen | |
| Yu et al | 2016 | SWCNT | Chitosan | paclitaxel | A549 | Cell proliferation was inhibited | |
| Al Faraj et al | 2016 | SWCNT | Polyvinylpyrrolidone | Doxorubicin | Mice lungs | Treatment was more effective | |
| Razzazan et al | 2016 | SWCNT | Polyethylene glycol | Gemcitabine | A549 | Anti-tumor efficacy was seen | |
| Pratap Singh et al | 2016 | MWCNT | Alpha-tocopheryl polyethylene glycol 1000 succinate | Docetaxel/coumarin-6 | A549 | Results confirmed that MWCNT are efficient nan-carrier | |
| Pratap Singh et al | 2016 | MWCNT | Alpha-tocopheryl polyethylene glycol 1000 succinate | Docetaxel/coumarin-6 | A549 | Efficacy with safety was seen | |
| Kim et al | 2017 | MWCNT | Polyethylene glycol | …. | Mitochondria in lung cancer cells (A549, and NHFB) | Anti-lung cancer efficacy was seen | |
| Attri et al | 2017 | MWCNT | Graphene oxide | …. | A549, and H460 | The hopeful result was observed | |
| Pratap Singh et al | 2017 | MWCNT | Chitosan | Docetaxel/coumarin-6 | A549 | Results were desirable | |
| Heger et al | 2017 | MWCNT | Polyethylene glycol | VP-16 and Bcl-2-targeted antisense | DMS53, and NCIH2135 | Hypersensitivity to this drug was observed | |
| Su et al | 2017 | MWCNT | Polyethyleneimine | iRGD | A549 | Treatment was effective | |
| Neha et al | 2018 | SWCNT | Chitosan | Curcumin | A549 | Cell proliferation was inhibited and apoptosis was induced | |
| Suo et al | 2018 | MWCNT | Polyethylene glycol | …. | Multi-drug resistance cells | The hopeful result was observed | |
| Cao et al | 2019 | SWCNT | Polyethylenimine with betaine | A549 | Anti-tumor effects were seen | ||
| Giuseppe Cirillo et al | 2019 | MWCNT | Chitosan | Methotrexate | MRC-5, and H1299 | Less toxicity for healthy cells and more anti-tumor effect were confirmed |
Notes: A brief description of the cells mentioned: (A549, NCI-H460, H1703, Calu 6, NHFB, H460, NCIH2135, and H1299 are non-small cell lung cancer cell lines), (DMS53 is small cell lung cancer cell line), (MRC-5 is fibroblast cell line).